Leapfrog Acquisition Corp. 10-Q Summary
Business Context and Reporting Period
Company: Leapfrog Acquisition Corp. (Leapfrog)
Reporting Period: Quarter ended September 30, 2025 (Inception: June 20, 2025)
Status: Cayman Islands exempted company; Shell Company; Emerging Growth Company.
Business Model: Blank check company formed to effect a merger, amalgamation, or business combination. No operations or revenues generated as of the balance sheet date.
Key Financial Metrics
| Metric | Value (Inception to Sept 30, 2025) |
|---|---|
| Total Assets | $295,429 (Deferred offering costs) |
| Total Liabilities | $331,318 |
| Shareholder's Deficit | ($35,889) |
| Net Loss | ($60,889) |
| Working Capital | ($331,318) Deficit |
| Cash Balance | $0 |
| Debt (Promissory Note) | $75,124 (Related party) |
Material Changes and Subsequent Events
The financial statements reflect the pre-IPO period. Significant liquidity and capital structure changes occurred subsequent to the reporting period:
- Initial Public Offering (IPO): Consummated on December 8, 2025. Sold 14,375,000 Units (including full over-allotment) at $10.00 per unit, generating gross proceeds of $143,750,000.
- Private Placement: Simultaneously sold 472,500 Private Placement Units to the Sponsor and underwriters for $4,725,000.
- Trust Account: $143,750,000 deposited into the Trust Account.
- Liquidity Shift: Post-IPO, the company held $1,395,995 in its operating bank account, resulting in a working capital surplus of $1,390,659.
- Debt Repayment: The $75,124 promissory note to the Sponsor was repaid in full upon IPO closing.
Outlook, Risks, and Management Commentary
- Going Concern: As of September 30, 2025, management noted substantial doubt about the ability to continue as a going concern due to a working capital deficit. This doubt was alleviated by the proceeds from the December 2025 IPO.
- Completion Window: The company has 24 months from the IPO closing (December 8, 2025) to consummate a business combination, subject to extension.
- Redemption Rights: Public shareholders may redeem shares for a pro-rata portion of the Trust Account if a business combination is not completed or upon certain amendments.
- Risk Factors: Geopolitical instability (Russia-Ukraine, Israel-Hamas), market volatility, and the risk of failing to identify a suitable target within the completion window.
- Transaction Costs: Total transaction costs were $8,293,874, including $2,875,000 in cash underwriting fees and $5,031,250 in deferred underwriting commissions.
Investor Verification Checklist
- Trust Account Status: Verify the $143,750,000 deposit and the identity of the trustee (Odyssey Transfer and Trust Company).
- Share Structure: Confirm the 25% ownership stake held by the Sponsor (Founder Shares) and the conversion terms of Class B to Class A shares.
- Warrant Terms: Review the exercise price ($11.50) and redemption triggers ($18.00 per share) for Public and Private Warrants.
- Deferred Fees: Note the $5,031,250 deferred underwriting commission payable only upon a successful business combination.
- Extension Provisions: Review the specific mechanisms and shareholder vote requirements for extending the 24-month completion window.